The Daily Pennsylvanian1d
NIH terminates three Penn research grants, citing incompatibility with ‘agency priorities’
The termination letters, obtained by the DP, told the researchers that their awards were “incompatible with agency priorities ...
CIDRAP7d
Estimates: Jynneos mpox vaccine 84% and 35% effective in people without, with HIV
One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...
Trump cuts to USAID halt funding for global vaccinations
The U.S. plans to cut funding for Gavi, which provides lifesaving vaccinations for millions of people in the world’s poorest ...
The Citizen1d
First HIV cure clinical trial in Africa shows promise in women
The clinical trial, dubbed FRESH and conducted in Durban, South Africa, revealed that four out of 20 women with acute HIV ...
MIT Technology Review12d
This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Devdiscourse3h
Trump Administration Axes Vaccine Aid Amid 'America First' Policy
The Trump administration plans to cease U.S. funding for Gavi, a vital organization aiding vaccine procurement for children ...
Q&A: Nobel Prize-winning researcher and BU grad discusses vaccine development, vaccine hesitancy, and preparing for another pandemic
Weissman was jointly awarded the 2023 Nobel Prize in Medicine with Katalin Karikó for discoveries which made COVID-19 ...
Healio7d
Increasing HPV vaccine coverage may decrease cancers among people with HIV
Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from ...